Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Inflammatory Bowel Diseases

Free Subscription Articles published in Aliment Pharmacol Ther Retrieve available abstracts of 108 articles: HTML format Text format

Single Articles

March 2010
1. NICHOLLS RJ , Clark DN, Kelso L, Crowe AM, et al
   Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. YAMAMOTO S , Nakase H, Chiba T
   Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis: authors' reply.
   Aliment Pharmacol Ther. 2010;31:677-8.
   PubMed     Text format     Related articles   
   
   
   
3. ROMANO C , Comito D, Famiani A, Fries W, et al
   Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis.
   Aliment Pharmacol Ther. 2010;31:676-7.
   PubMed     Text format     Related articles   
   
   
   February 2010
4. NEWNHAM E , Gearry R, Gibson P
   Factors associated with radiation exposure in patients with inflammatory bowel disease.
   Aliment Pharmacol Ther. 2010;31:534-5.
   PubMed     Text format     Related articles   
   
   
   January 2010
5. COHEN RD , Yu AP, Wu EQ, Xie J, et al
   Systematic review: costs of ulcerative colitis in Western countries.
   Aliment Pharmacol Ther. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
6. ODES S , Vardi H, Friger M, Esser D, et al
   Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis.
   Aliment Pharmacol Ther. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. R ANSARI A , Patel N, Sanderson J, O'Donohue J, et al
   Low dose azathioprine or 6-mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
   Aliment Pharmacol Ther. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. LEVI Z , Fraser E, Krongrad R, Hazazi R, et al
   Factors associated with radiation exposure in patients with inflammatory bowel disease.
   Aliment Pharmacol Ther. 2009;30.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
9. ZABANA Y , Domenech E, Manosa M, Garcia-Planella E, et al
   Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice.
   Aliment Pharmacol Ther. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. YANG Z , Wu Q, Wu K, Fan D, et al
    Meta-analysis: preoperative infliximab treatment and short-term postoperative complications in patients with ulcerative colitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. CELASCO G , Papa A, Jones R, Moro L, et al
    Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
12. OUSSALAH A , Roblin X, Laharie D, Filippi J, et al
    Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey.
    Aliment Pharmacol Ther. 2009;30:854-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. ELKJAER M , Burisch J, Voxen Hansen V, Deibjerg Kristensen B, et al
    A new rapid home test for faecal calprotectin in ulcerative colitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. RAHIER JF , Yazdanpanah Y, Viget N, Travis S, et al
    Systematic review: influenza A (H1N1) virus in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. BOUGUEN G , Trouilloud I, Siproudhis L, Oussalah A, et al
    Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
    Aliment Pharmacol Ther. 2009;30:749-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
16. MOSHKOVSKA T , Stone MA, Clatworthy J, Smith RM, et al
    An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self report and urinary drug excretion measurements.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. MURPHY SJ , Wang L, Anderson LA, Steinlauf A, et al
    Withdrawal of corticosteroids in inflammatory bowel disease patients after dependency periods ranging from 2 to 45 years: A proposed method.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
18. BERMEJO F , Lopez-Sanroman A, Algaba A, VAN-Domselaar M, et al
    Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. PRANTERA C , Kohn A, Campieri M, Caprilli R, et al
    Clinical trial: Ulcerative colitis maintenance treatment with 5-ASA - a 1-year, randomized multicentre study comparing MMX with Asacol.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. J SHALE M , H Seow C, S Coffin C, G Kaplan G, et al
    Review article: Chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
21. DAPERNO M , Sostegni R, Canaparo R, Serpe L, et al
    Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. BAARS JE , Zelinkova Z, Mensink PB, Markus T, et al
    High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patient organization: a patient empowerment study.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
23. GOEL A , Mittal A, Evstatiev R, Nemeth M, et al
    In vivo effects of mesalazine or E.Coli Nissle 1917 on microsatellite instability in ulcerative colitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. WAHED M , Louis-Auguste JR, Baxter LM, Limdi JK, et al
    Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine/mercaptopurine.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. SMITH M , Marinaki A, Arenas M, Shobowale-Bakre M, et al
    Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
26. MOORE L , Tang L, Lopez R, Shen B, et al
    Clinical features of ileal pouch-anal anastomosis in African American patients with underlying ulcerative colitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. YAMAMOTO T , Nakahigashi M, R Saniabadi A
    Review article: diet and inflammatory bowel disease - epidemiology and treatment.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. SCHNEEWEISS S , Korzenik J, Solomon DH, Canning C, et al
    Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. COTEUR G , Feagan B, Keininger DL, Kosinski M, et al
    Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's disease.
    Aliment Pharmacol Ther. 2009;29:1032-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. AMRE DK , Mack DR, Morgan K, Israel D, et al
    Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease.
    Aliment Pharmacol Ther. 2009;29:1025-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
31. GISBERT JP , Linares PM, McNicholl AG, Mate J, et al
    Meta-analysis: efficacy of azathioprine and mercaptopurine in ulcerative colitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. MANES G , Bianchi Porro G
    Missed lesions with conventional endoscopy discovered by double-balloon enteroscopy: endoscopist or instrument?
    Aliment Pharmacol Ther. 2009;29:918-9.
    PubMed     Text format     Related articles   
    
    
    March 2009
33. SHAO LM , Chen MY, Cai JT
    Meta-analysis: the efficacy and safety of certolizumab pegol in Crohn's disease.
    Aliment Pharmacol Ther. 2009;29:605-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. LICHTENSTEIN GR , Bengtsson B, Hapten-White L, Rutgeerts P, et al
    Oral budesonide for maintenance of remission of Crohn's disease: a pooled safety analysis.
    Aliment Pharmacol Ther. 2009;29:643-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. HO GT , Mowat A, Potts L, Cahill A, et al
    Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004-2008).
    Aliment Pharmacol Ther. 2009;29:527-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. SHEN B , Remzi FH, Lavery IC, Lopez R, et al
    Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch.
    Aliment Pharmacol Ther. 2009;29:519-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
37. GRAY JR , Leung E, Scales J
    A survey of ulcerative colitis patient preferences and satisfaction with therapy Treatment of ulcerative colitis from the patient's perspective: a survey of preferences and satisfaction with therapy.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. SEKSIK P , Cosnes J, Sokol H, Nion-Larmurier I, et al
    Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. OUSSALAH A , Babouri A, Chevaux JB, Stancu L, et al
    Adalimumab for Crohn's disease with intolerance or lost response to infliximab: a 3-year single-centre experience.
    Aliment Pharmacol Ther. 2009;29:416-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. FIORINO G , Allez M, Alberto M, Danese S, et al
    Anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. LEES CW , Ali AI, Thompson AI, Ho GT, et al
    The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.
    Aliment Pharmacol Ther. 2009;29:286-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. ROMANATO G , Scarpa M, Angriman I, Faggian D, et al
    Plasma lipids and inflammation in active inflammatory bowel diseases.
    Aliment Pharmacol Ther. 2009;29:298-307.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. PELLETIER AL , Kalisazan B, Wienckiewicz J, Bouarioua N, et al
    Infliximab treatment for symptomatic Crohn's disease strictures.
    Aliment Pharmacol Ther. 2009;29:279-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. SWAMINATH A , Ullman T, Rosen M, Mayer L, et al
    Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naive patients.
    Aliment Pharmacol Ther. 2009;29:273-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
45. CHOW DK , Sung JJ, Tsoi KK, Wong VW, et al
    Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory Bowel Disease: analysis of a Chinese Cohort Study.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. KANE SV , Accortt NA, Magowan S, Brixner D, et al
    Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis.
    Aliment Pharmacol Ther. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
47. HINDORF U , Johansson M, Eriksson A, Kvifors E, et al
    Mercaptopurine treatment should be considered in Azathioprine intolerant patients with Inflammatory Bowel Disease.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. M ANDREWS J , Travis SP, Gibson PR, Gasche C, et al
    Does concurrent therapy with 5-ASA and immunomodulator(s) in inflammatory bowel disease improve outcomes?
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. STORR M , Emmerdinger D, Diegelmann J, Yuce B, et al
    The role of Fatty Acid Hydrolase (FAAH) gene variants in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
50. KITAZAKI S , Mitsuyama K, Masuda J, Harada K, et al
    Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. MULANI P , Chao J
    Infliximab vs. Adalimumab for Crohn's disease.
    Aliment Pharmacol Ther. 2008;28:1265-6.
    PubMed     Text format     Related articles   
    
    
    
52. LAWRANCE IC , Copeland TS
    Rectal tacrolimus in the treatment of resistant ulcerative proctitis.
    Aliment Pharmacol Ther. 2008;28:1214-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. CHRISTENSEN LA , Dahlerup JF, Nielsen MJ, Fallingborg JF, et al
    Azathioprine treatment during lactation.
    Aliment Pharmacol Ther. 2008;28:1209-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. SIPPONEN T , Karkkainen P, Savilahti E, Kolho KL, et al
    Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.
    Aliment Pharmacol Ther. 2008;28:1221-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. RUSSO EA , Harris AW, Campbell S, Lindsay J, et al
    Experience of maintenance Infliximab therapy for refractory ulcerative colitis from six centres in England.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. LEES CW , Ali A, Thompson AI, Ho GT, et al
    The safety profile of anti-TNF therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
57. PEYRIN-BIROULET L , Cadranel JF, Nousbaum JB, Oussalah A, et al
    Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression.
    Aliment Pharmacol Ther. 2008;28:984-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. HIGGINS PD , Rubin DT, Kaulback K, Schoenfield PS, et al
    Systematic review: Impact of non-adherence to 5-ASA products on the frequency and cost of ulcerative colitis flares.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
59. BUCKLAND A , Bodger K
    The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. IRVINE EJ , Yeh CH, Ramsey D, Stirling AL, et al
    The effect of mesalamine therapy on quality of life in patients with mildly to moderately active ulcerative colitis.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. PENA-ROSSI C , Schreiber S, Golubovic G, Mertz-Nielsen A, et al
    Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis.
    Aliment Pharmacol Ther. 2008;28:758-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. ANSARI A , Elliott T, Baburajan B, Mayhead P, et al
    Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.
    Aliment Pharmacol Ther. 2008;28:734-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. PASTORELLI L , Saibeni S, Spina L, Signorelli C, et al
    Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis.
    Aliment Pharmacol Ther. 2008;28:581-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. PASCUA M , Su C, Lewis JD, Brensinger C, et al
    Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn's disease.
    Aliment Pharmacol Ther. 2008;28:545-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
65. TSAI HH , Punekar Y, Morris J, Fortun P, et al
    A model of the long-term cost-effectiveness of scheduled maintenance treatment with infliximab for moderate to severe ulcerative colitis.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. WEST RL , Zelinkova Z, Wolbink GJ, Kuipers EJ, et al
    Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn;s disease.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
67. OUSSALAH A , Laclotte C, Chevaux JB, Bensenane M, et al
    Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience.
    Aliment Pharmacol Ther. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. NG SC , Kamm MA
    Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. ANSARI A , Arenas M, Greenfield S, Morris D, et al
    Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. MOSS AC , Fernandez-Becker N, Jo Kim K, Cury D, et al
    The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease.
    Aliment Pharmacol Ther. 2008;28:221-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. LINDSAY J , Punekar YS, Morris J, Chung-Faye G, et al
    Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn's disease--modelling outcomes in active luminal and fistulizing disease in adults.
    Aliment Pharmacol Ther. 2008;28:76-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
72. ANSARI A , Elliott T, Baburajan B, Mayhead P, et al
    Long term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. PENA-ROSSI C , Schreiber S, Golubovic G, Mertz-Nielsen A, et al
    Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-1a in moderately active ulcerative colitis.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. LAU A , Chande N, Ponich T, Gregor JC, et al
    Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. HUTFLESS S , Fireman B, Kane S, Herrinton LJ, et al
    Screening differences and risk of cervical cancer in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. YAMAMOTO S , Nakase H, Mikami S, Inoue S, et al
    Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. LICHTENSTEIN GR , Kamm MA
    Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis - methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. PANACCIONE R , Rutgeerts P, Sandborn WJ, Feagan B, et al
    Review article: treatment algorithms to maximise remission and minimise corticosteroid dependence in patients with inflammatory bowel disease: a time bound approach.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. MIKOCKA-WALUS AA , Turnbull DA, Andrews JM, Moulding NT, et al
    The effect of functional gastrointestinal disorders (FGIDs) on psychological co-morbidity and quality of life in patients with inflammatory bowel disease (IBD).
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. TINE F , Rossi F, Sferrazza A, Orlando A, et al
    Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease.
    Aliment Pharmacol Ther. 2008;27:1210-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. LEIPER K , Martin K, Ellis A, Watson AJ, et al
    Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease.
    Aliment Pharmacol Ther. 2008;27:1233-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
82. BERMEJO F , Lopez-Sanroman A, Taxonera C, Gisbert JP, et al
    Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. GISBERT JP , Nino P, Cara C, Rodrigo L, et al
    Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study on 394 patients.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. KOLTUN WA
    Endoscopic dilatation in Crohn's disease.
    Aliment Pharmacol Ther. 2008;27:994-5.
    PubMed     Text format     Related articles   
    
    
    
85. MCLAUGHLIN SD , Clark SK, Tekkis PP, Ciclitira PJ, et al
    Review article: restorative proctocolectomy, indications, management of complications and follow-up--a guide for gastroenterologists.
    Aliment Pharmacol Ther. 2008;27:895-909.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. MATSUKURA H , Ikeda S, Yoshimura N, Takazoe M, et al
    Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn's disease.
    Aliment Pharmacol Ther. 2008;27:765-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
87. HAWTHORNE AB , Rubin G, Ghosh S
    Review article: medication non-adherence in ulcerative colitis - strategies to improve adherence with mesalazine and other maintenance therapies.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. LICHTENSTEIN GR , Kamm MA, Sandborn WJ, Lyne A, et al
    MMX(trade mark) mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient sub-populations.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. HANAUER SB
    Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
    Aliment Pharmacol Ther. 2008;27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. ROBINSON A
    Review article: improving adherence to medication in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2008;27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. WESTWOOD N , Travis SP
    Review article: what do patients with inflammatory bowel disease want for their clinical management?
    Aliment Pharmacol Ther. 2008;27.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
92. HO GT , Smith L, Aitken S, Lee HM, et al
    The use of adalimumab in the management of refractory Crohn's disease.
    Aliment Pharmacol Ther. 2008;27:308-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. DAY AS , Whitten KE, Sidler M, Lemberg DA, et al
    Systematic review: nutritional therapy in paediatric Crohn's disease.
    Aliment Pharmacol Ther. 2008;27:293-307.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. O DONNELL S , O Morain C
    Review article: the use of anti-TNF therapy in inflammatory bowel disease during pregnancy and conception.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. GUNESH S , Thomas GA, Williams GT, Roberts A, et al
    The incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996-2005.
    Aliment Pharmacol Ther. 2008;27:211-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. LATIANO A , Palmieri O, Valvano MR, D'Inca R, et al
    The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Aliment Pharmacol Ther. 2008;27:241-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
97. DE SCHEPPER HU , De Man JG, Moreels TG, Pelckmans PA, et al
    Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. D'INCA R , Bertomoro P, Mazzocco K, Vettorato MG, et al
    Risk factors for non-adherence to medication in inflammatory bowel disease patients.
    Aliment Pharmacol Ther. 2008;27:166-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. ROEDIGER WE
    Review article: nitric oxide (NO) from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. NOBLE CL , McCullough J, Ho W, Lees CW, et al
     Low body mass not vitamin d receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease.
     Aliment Pharmacol Ther. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. AKOBENG AK
     Review article: the evidence base for interventions used to maintain remission in Crohn's disease.
     Aliment Pharmacol Ther. 2008;27:11-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2007
102. WEERSMA RK , van Dullemen HM, van der Steege G, Nolte IM, et al
     Review article: Inflammatory bowel disease and genetics.
     Aliment Pharmacol Ther. 2007;26 Suppl 2:57-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. TAMINIAU JA
     Review article: The clinical importance of growth in children with inflammatory bowel disease: is it important to the gastroenterologist?
     Aliment Pharmacol Ther. 2007;26 Suppl 2:53-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. VLEGGAAR FP , Lutgens MW, Claessen MM
     Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
     Aliment Pharmacol Ther. 2007;26 Suppl 2:47-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. JONKERS D , Stockbrugger R
     Review article: Probiotics in gastrointestinal and liver diseases.
     Aliment Pharmacol Ther. 2007;26 Suppl 2:133-48.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. VAN DEN BROEK FJ , Fockens P, Dekker E
     Review article: New developments in colonic imaging.
     Aliment Pharmacol Ther. 2007;26 Suppl 2:91-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2007
107. SARO C , da la Coba C, Casado MA, Morales JM, et al
     Resource use in patients with Crohn's disease treated with infliximab.
     Aliment Pharmacol Ther. 2007;26:1313-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. ARATARI A , Papi C, Leandro G, Viscido A, et al
     Early versus late surgery for ileo-caecal Crohn's disease.
     Aliment Pharmacol Ther. 2007;26:1303-12.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: